NEK6
MOLECULAR TARGETNIMA related kinase 6
NEK6 (NIMA related kinase 6) is targeted by 11 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting NEK6
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | tae 684 | 3.43 | 30 |
| 2 | fedratinib | 3.40 | 29 |
| 3 | dovitinib | 3.09 | 21 |
| 4 | lestaurtinib | 3.04 | 20 |
| 5 | r 406 | 2.83 | 16 |
| 6 | milciclib | 2.77 | 15 |
| 7 | kw 2449 | 2.64 | 13 |
| 8 | ast 487 | 2.56 | 12 |
| 9 | bms 754807 | 2.30 | 9 |
| 10 | su 014813 | 2.20 | 8 |
| 11 | Quercetin | 0.69 | 1 |
About NEK6 as a Drug Target
NEK6 (NIMA related kinase 6) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 11 compounds with documented NEK6 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
NEK6 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.